These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37289320)

  • 1. Zoledronic acid after spinal cord injury mitigates losses in proximal femoral strength independent of ambulation ability.
    Crack LE; Haider IT; Simonian N; Barroso J; Gabel L; Schnitzer TJ; Edwards WB
    Osteoporos Int; 2023 Sep; 34(9):1637-1645. PubMed ID: 37289320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial.
    Goenka S; Sethi S; Pandey N; Joshi M; Jindal R
    Spinal Cord; 2018 Dec; 56(12):1207-1211. PubMed ID: 30258212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study.
    Bauman WA; Cirnigliaro CM; La Fountaine MF; Martinez L; Kirshblum SC; Spungen AM
    J Bone Miner Metab; 2015 Jul; 33(4):410-21. PubMed ID: 25158630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study.
    Oleson CV; Marino RJ; Formal CS; Modlesky CM; Leiby BE
    Spinal Cord; 2020 Aug; 58(8):921-929. PubMed ID: 32055041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in proximal femoral strength in patients with acute spinal cord injury.
    Edwards WB; Schnitzer TJ; Troy KL
    J Bone Miner Res; 2014 Sep; 29(9):2074-9. PubMed ID: 24677293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time.
    Haider IT; Lobos SM; Simonian N; Schnitzer TJ; Edwards WB
    Osteoporos Int; 2018 Dec; 29(12):2703-2715. PubMed ID: 30334093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury.
    Shapiro J; Smith B; Beck T; Ballard P; Dapthary M; BrintzenhofeSzoc K; Caminis J
    Calcif Tissue Int; 2007 May; 80(5):316-22. PubMed ID: 17417700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional electrical stimulation (FES)-assisted rowing combined with zoledronic acid, but not alone, preserves distal femur strength and stiffness in people with chronic spinal cord injury.
    Fang Y; Morse LR; Nguyen N; Battaglino RA; Goldstein RF; Troy KL
    Osteoporos Int; 2021 Mar; 32(3):549-558. PubMed ID: 32888047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral loss at the proximal femur in acute spinal cord injury.
    Edwards WB; Schnitzer TJ; Troy KL
    Osteoporos Int; 2013 Sep; 24(9):2461-9. PubMed ID: 23468075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability and delayed treatment effects of zoledronic acid on bone loss after spinal cord injury: a randomized, controlled trial.
    Edwards WB; Haider IT; Simonian N; Barroso J; Schnitzer TJ
    J Bone Miner Res; 2021 Nov; 36(11):2127-2138. PubMed ID: 34278611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral and stiffness loss at the distal femur and proximal tibia in acute spinal cord injury.
    Edwards WB; Schnitzer TJ; Troy KL
    Osteoporos Int; 2014 Mar; 25(3):1005-15. PubMed ID: 24190426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury.
    Bubbear JS; Gall A; Middleton FR; Ferguson-Pell M; Swaminathan R; Keen RW
    Osteoporos Int; 2011 Jan; 22(1):271-9. PubMed ID: 20358358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of Volumetric Bone Mineral Density Parameters in Men with Spinal Cord Injury.
    Maïmoun L; Gelis A; Serrand C; Mura T; Humbert L; Boudousq V; de Santa-Barbara P; Laux D; Fattal C; Mariano-Goulart D
    Calcif Tissue Int; 2023 Sep; 113(3):304-316. PubMed ID: 37353625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the evolution of cortical and trabecular bone compartments in the proximal femur after spinal cord injury by 3D-DXA.
    Gifre L; Humbert L; Muxi A; Del Rio L; Vidal J; Portell E; Monegal A; Guañabens N; Peris P
    Osteoporos Int; 2018 Jan; 29(1):201-209. PubMed ID: 29043391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Sublesional Bone Loss Extends into the Second Decade After Spinal Cord Injury.
    Cirnigliaro CM; Myslinski MJ; Asselin P; Hobson JC; Specht A; La Fountaine MF; Kirshblum SC; Forrest GF; Dyson-Hudson T; Spungen AM; Bauman WA
    J Clin Densitom; 2019; 22(2):185-194. PubMed ID: 30503961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronic Acid Treatment After Acute Spinal Cord Injury: Results of a Randomized, Placebo-Controlled Pilot Trial.
    Schnitzer TJ; Kim K; Marks J; Yeasted R; Simonian N; Chen D
    PM R; 2016 Sep; 8(9):833-43. PubMed ID: 26828618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
    Eastell R; Lang T; Boonen S; Cummings S; Delmas PD; Cauley JA; Horowitz Z; Kerzberg E; Bianchi G; Kendler D; Leung P; Man Z; Mesenbrink P; Eriksen EF; Black DM;
    Osteoporos Int; 2010 Jul; 21(7):1277-85. PubMed ID: 19802508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label clinical trial of alendronate after teriparatide therapy in people with spinal cord injury and low bone mineral density.
    Haider IT; Simonian N; Saini AS; Leung FM; Edwards WB; Schnitzer TJ
    Spinal Cord; 2019 Oct; 57(10):832-842. PubMed ID: 31164732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of High-Impact Exercise on Cortical and Trabecular Bone Mineral Content and 3D Distribution Across the Proximal Femur in Older Men: A Randomized Controlled Unilateral Intervention.
    Allison SJ; Poole KE; Treece GM; Gee AH; Tonkin C; Rennie WJ; Folland JP; Summers GD; Brooke-Wavell K
    J Bone Miner Res; 2015 Sep; 30(9):1709-16. PubMed ID: 25753495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-lasting bisphosphonate partially protects periprosthetic bone, but does not enhance initial stability of uncemented femoral stems: A randomized placebo-controlled trial of women undergoing total hip arthroplasty.
    Aro E; Moritz N; Mattila K; Aro HT
    J Biomech; 2018 Jun; 75():35-45. PubMed ID: 29747966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.